You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Alcon Pharms Ltd Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ALCON PHARMS LTD, and what generic and branded alternatives to ALCON PHARMS LTD drugs are available?

ALCON PHARMS LTD has fourteen approved drugs.



Summary for Alcon Pharms Ltd
US Patents:0
Tradenames:13
Ingredients:13
NDAs:14

Drugs and US Patents for Alcon Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE dexamethasone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 062721-001 Nov 17, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe
Alcon Pharms Ltd NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate; neomycin sulfate SOLUTION/DROPS;OPHTHALMIC 062714-001 Jul 21, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe
Alcon Pharms Ltd BETAXON levobetaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 021114-001 Feb 23, 2000 DISCN No No ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alcon Pharms Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon Pharms Ltd BETAXON levobetaxolol hydrochloride SUSPENSION/DROPS;OPHTHALMIC 021114-001 Feb 23, 2000 4,911,920*PED ⤷  Subscribe
Alcon Pharms Ltd TRAVATAN travoprost SOLUTION/DROPS;OPHTHALMIC 021257-001 Mar 16, 2001 6,011,062 ⤷  Subscribe
Alcon Pharms Ltd NAVSTEL calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate SOLUTION;IRRIGATION 022193-001 Jul 24, 2008 7,084,130 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ALCON PHARMS LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Ophthalmic Solution 0.03% ➤ Subscribe 2004-12-23
➤ Subscribe Ophthalmic Solution 0.00% ➤ Subscribe 2008-11-28
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.